In-FI Fiasp: Comparison of postprandial glycemic control in non-critically ill hospitalized patients with type 2 diabetes mellitus using Novolog vs. Fiasp insulin: a Randomized Controlled Open Label Trial (In-FI)11/01/2020 - 10/31/2024 (PI)
Novo Nordisk
Linagliptin Trial: A randomized controlled trial on the safety and efficacy of linagliptin(Tradjenta10/01/2013 - 09/30/2017 (PI)
Emory University Boehringer Ingelheim